Also and in accordance with previously described miR-17 upregulation in RRMS patients [22], the analysis of CD4+ T cell proliferation upon in vitro stimulation revealed a significant increase in the proliferating capacity of lymphocytes from untreated RRMS patients compared to HVs (Figure 5(b) right panel). This evidence concerns the gene CD4 and relapsing-remitting multiple sclerosis.